Back to News
Market Impact: 0.18
Novavax (NVAX) Soars 7.0%: Is Further Upside Left in the Stock?
Source: zacks.com
Analyst EstimatesMarket Technicals & FlowsHealthcare & Biotech
Novavax shares rose in the latest session on above-average trading volume, signaling near-term buying interest. However, the trend in earnings-estimate revisions does not support expectations for sustained upside, creating a cautious outlook for the stock.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
NVAX-0.35
More News
- Stocks face a key hurdle in next week’s U.S.-China summit. Here’s what’s at stake
- Tokenization is set to change stock trading. These stocks could get a boost
- FTSE 100 today: Stocks drop as Hormuz tanker hit, Aramco cuts Europe supply
- Bank of Japan Hikes Interest Rates in a Split Vote; Yen Drops
- Buffett Steps Down at Berkshire
- European stocks snap two-week slide as Fed resolve